BENFAREMO, Devis
 Distribuzione geografica
Continente #
NA - Nord America 2.931
EU - Europa 1.342
AS - Asia 981
SA - Sud America 250
AF - Africa 105
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.612
Nazione #
US - Stati Uniti d'America 2.887
IT - Italia 431
SG - Singapore 404
CN - Cina 234
BR - Brasile 209
RU - Federazione Russa 162
IE - Irlanda 130
HK - Hong Kong 128
UA - Ucraina 117
DE - Germania 116
SE - Svezia 116
VN - Vietnam 69
GB - Regno Unito 68
CI - Costa d'Avorio 58
FR - Francia 46
FI - Finlandia 37
IN - India 32
DK - Danimarca 31
MA - Marocco 24
CA - Canada 23
TR - Turchia 23
AT - Austria 22
KR - Corea 21
PL - Polonia 20
AR - Argentina 18
JP - Giappone 18
NL - Olanda 18
MX - Messico 12
ZA - Sudafrica 11
BE - Belgio 10
TW - Taiwan 10
BD - Bangladesh 8
IQ - Iraq 7
CO - Colombia 6
EG - Egitto 5
CH - Svizzera 4
EC - Ecuador 4
ES - Italia 4
ID - Indonesia 4
LT - Lituania 4
IL - Israele 3
JM - Giamaica 3
PY - Paraguay 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
VE - Venezuela 3
AZ - Azerbaigian 2
CL - Cile 2
GR - Grecia 2
KE - Kenya 2
MY - Malesia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PK - Pakistan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BO - Bolivia 1
CG - Congo 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
MU - Mauritius 1
NA - Namibia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 5.612
Città #
Ashburn 395
Chandler 330
Singapore 253
Dallas 196
Fairfield 173
Jacksonville 139
Dublin 128
Hong Kong 126
Des Moines 120
New York 106
Boardman 86
Wilmington 84
Woodbridge 82
Seattle 77
Houston 71
Beijing 68
Los Angeles 67
Centro 63
Abidjan 58
Munich 51
Lawrence 49
Princeton 49
Ancona 47
Ann Arbor 46
Cambridge 44
The Dalles 44
Redmond 40
Moscow 34
San Mateo 33
Ho Chi Minh City 29
São Paulo 26
San Diego 24
Buffalo 23
Tolentino 23
Turin 22
Chicago 20
Hanoi 20
Washington 20
London 19
Warsaw 19
Hefei 18
Milan 18
Turku 18
Brooklyn 14
Rome 14
Poplar 12
Pune 12
Atlanta 11
Denver 11
Montreal 11
Santa Clara 11
Brussels 10
Columbus 10
Orem 10
Chennai 9
Iesi 9
Marche 9
Nuremberg 9
Tokyo 9
Boston 8
Johannesburg 8
Monte San Pietrangeli 8
San Francisco 8
Vienna 8
Wuhan 8
Brasília 7
Guangzhou 7
Manchester 7
Norwalk 7
Shanghai 7
Amandola 6
Belo Horizonte 6
Cagliari 6
Frankfurt am Main 6
Helsinki 6
Phoenix 6
West Jordan 6
Aversa 5
Comunanza 5
Jesi 5
Osimo 5
Ostra 5
Porto 5
Rio de Janeiro 5
Sassoferrato 5
Stockholm 5
Taichung 5
Taipei 5
Amsterdam 4
Calgary 4
Charlotte 4
Council Bluffs 4
Curitiba 4
Falls Church 4
Mexico City 4
Mumbai 4
Naples 4
Querétaro 4
San Giorgio A Cremano 4
Seoul 4
Totale 3.757
Nome #
Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 162
ACCURACY OF DUAL-ENERGY COMPUTED TOMOGRAPHY FOR THE DETECTION OF BONE MARROW EDEMA IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS 160
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 145
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 143
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis 136
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 130
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 127
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 125
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy 125
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 122
6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study 122
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 121
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 119
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 119
Biologics in inflammatory immune-mediated systemic diseases 116
Certolizumab pegol for the treatment of psoriasis 115
A painful diagnosis 115
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 113
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 111
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 109
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 108
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 108
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 106
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 105
Chronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren's syndrome 105
Videofluorography swallow study in patients with systemic sclerosis: correlation with clinical and radiological features 102
MULTICENTER VALIDATION OF THE DETECTION OF ARTHRITIS IN INFLAMMATORY BOWEL DISEASES (DETAIL) QUESTIONNAIRE FOR THE SCREENING OF SPONDYLOARTHRITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 101
Patient reported outcomes and assessment of the quality of life in a cohort of patients affected by enteropathic spondyloarthritis: results of a monocentric prospective observational study at one year 98
Biologics in inflammatory and immunomediated arthritis 94
Putative functional pathogenic autoantibodies in systemic sclerosis 91
Dual-energy computed tomography for the detection of sacroiliac joints bone marrow oedema in patients with axial spondyloarthritis 88
Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association 83
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 82
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 82
Dolore Articolare Acuto 81
Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors: A review of the literature 80
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 80
A young man with persistent dyspepsia: The unexpected virtue of proton-pump inhibitors 78
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 77
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 69
The neuropathic pain features in Psoriatic Arthritis: a cross-sectional evaluation of prevalence and associated factors 69
Current take on systemic sclerosis patients’ vaccination recommendations 67
Atypical Spontaneous Hematomas in a Patient with Severe Coronavirus Disease 2019 (COVID-19) 65
Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT Study 63
Pre-scleroderma and new opportunities for preventive medicine 63
Widespread painful nodules in a patient with rheumatoid arthritis 63
Diagnosis and management of leukocytoclastic vasculitis 61
Novel therapeutic approaches and treatment targets for psoriatic arthritis 58
Discharge from the emergency department and early hospital revaluation in patients with COVID-19 pneumonia: a prospective study 58
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 57
Safety of intermediate dose of low molecular weight heparin in COVID-19 patients 57
Enteropathic spondyloarthritis: Results from a large nationwide database analysis 56
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 55
Atypical neutrophilic panniculitis as presentation of BCR-ABL1-negative chronic myeloid leukaemia 55
Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study 53
Role of cognitive impairment and malnutrition as determinants of quality of life in patients with systemic sclerosis 53
Hypogammaglobulinemia in patients affected by limited cutaneous systemic sclerosis: Case series and review of the literature 52
Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine 48
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study 48
Speckle-tracking global longitudinal strain predicts death and cardiovascular events in patients with systemic sclerosis 46
Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician 46
Is there a future for anti-cd38 antibody therapy in systemic autoimmune diseases? 46
Tocilizumab for severe COVID-19 pneumonia 45
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 43
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 42
Skin ultrasound in systemic sclerosis: past, present and exciting future 41
Systemic Sclerosis: A Key Model of Endothelial Dysfunction 32
Doppler ultrasound, a noninvasive tool for the study of mesenteric arterial flow in systemic sclerosis: a cross-sectional study of a patient cohort with review and meta-analysis of the literature 27
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 22
Totale 5.844
Categoria #
all - tutte 31.567
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.567


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021355 0 0 0 0 0 34 54 73 49 55 45 45
2021/2022380 23 41 22 6 9 40 6 14 32 36 78 73
2022/2023898 68 103 67 79 44 201 11 53 187 10 59 16
2023/2024622 70 14 51 63 86 139 25 26 9 80 14 45
2024/20251.288 177 91 20 32 68 60 170 58 216 70 149 177
2025/20261.505 287 207 198 335 438 40 0 0 0 0 0 0
Totale 5.844